Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana
Identifieur interne : 000032 ( PascalFrancis/Corpus ); précédent : 000031; suivant : 000033Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana
Auteurs : Yaasir Mamoojee ; Shaid Shakoor ; Rebecca L. Gorton ; Stephen Sarfo ; Lambert T. Appiah ; Betty Norman ; Indran Balakrishnan ; Richard Phillips ; David ChadwickSource :
- TM & IH. Tropical medicine & international health [ 1360-2276 ] ; 2011.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
OBJECTIVES To determine the prevalence of cryptococcal antigenaemia in a clinic population with advanced HIV infection, with a view to giving antifungal therapy to those testing positive. METHODS Serum samples from adults with CD4 count <100 cells/mm3 presenting to a large HIV clinic in Kumasi, Ghana, were tested retrospectively for cryptococcal antigenaemia using a latex agglutination assay, and clinical and demographic data extracted from case notes. RESULTS Of 92 samples tested, two were positive thus giving a prevalence of 2% (95% CI, 0-5.2%). CONCLUSIONS The prevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme appears to be low in Kumasi, suggesting that the value of routine testing of outpatients diagnosed with advanced HIV infection may be limited in this population.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 11-0033262 INIST |
---|---|
ET : | Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana |
AU : | MAMOOJEE (Yaasir); SHAKOOR (Shaid); GORTON (Rebecca L.); SARFO (Stephen); APPIAH (Lambert T.); NORMAN (Betty); BALAKRISHNAN (Indran); PHILLIPS (Richard); CHADWICK (David) |
AF : | Department of Infection & Travel Medicine, The James Cook University Hospital/Middlesbrough/Royaume-Uni (1 aut., 2 aut., 9 aut.); Department of Microbiology, The Royal Free Hospital/London/Royaume-Uni (3 aut., 7 aut.); Department of Medicine, Komfo Anokye Teaching Hospital/Kumasi/Ghana (4 aut., 5 aut., 6 aut., 8 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | TM & IH. Tropical medicine & international health; ISSN 1360-2276; Royaume-Uni; Da. 2011; Vol. 16; No. 1; Pp. 53-56; Bibl. 1/2 p. |
LA : | Anglais |
EA : | OBJECTIVES To determine the prevalence of cryptococcal antigenaemia in a clinic population with advanced HIV infection, with a view to giving antifungal therapy to those testing positive. METHODS Serum samples from adults with CD4 count <100 cells/mm3 presenting to a large HIV clinic in Kumasi, Ghana, were tested retrospectively for cryptococcal antigenaemia using a latex agglutination assay, and clinical and demographic data extracted from case notes. RESULTS Of 92 samples tested, two were positive thus giving a prevalence of 2% (95% CI, 0-5.2%). CONCLUSIONS The prevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme appears to be low in Kumasi, suggesting that the value of routine testing of outpatients diagnosed with advanced HIV infection may be limited in this population. |
CC : | 002B01; 002B05D02L; 002B05C02D |
FD : | SIDA; Sérologie; Antiviral; Prévalence; Cryptococcose; Antigène; Homme; Virus immunodéficience humaine; Sang; Stade avancé; Antirétroviral; Ghana; Epidémiologie; Médecine tropicale |
FG : | Virose; Infection; Mycose; Lentivirus; Retroviridae; Virus; Afrique; Immunodéficit; Immunopathologie |
ED : | AIDS; Serology; Antiviral; Prevalence; Cryptococcosis; Antigen; Human; Human immunodeficiency virus; Blood; Advanced stage; Antiretroviral agent; Ghana; Epidemiology; Tropical medicine |
EG : | Viral disease; Infection; Mycosis; Lentivirus; Retroviridae; Virus; Africa; Immune deficiency; Immunopathology |
SD : | SIDA; Serología; Antiviral; Prevalencia; Criptococosis; Antígeno; Hombre; Human immunodeficiency virus; Sangre; Estadio avanzado; Antiretroviral; Ghana; Epidemiología; Medicina tropical |
LO : | INIST-26295.354000194051910070 |
ID : | 11-0033262 |
Links to Exploration step
Pascal:11-0033262Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana</title>
<author><name sortKey="Mamoojee, Yaasir" sort="Mamoojee, Yaasir" uniqKey="Mamoojee Y" first="Yaasir" last="Mamoojee">Yaasir Mamoojee</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Infection & Travel Medicine, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Shakoor, Shaid" sort="Shakoor, Shaid" uniqKey="Shakoor S" first="Shaid" last="Shakoor">Shaid Shakoor</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Infection & Travel Medicine, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gorton, Rebecca L" sort="Gorton, Rebecca L" uniqKey="Gorton R" first="Rebecca L." last="Gorton">Rebecca L. Gorton</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Microbiology, The Royal Free Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sarfo, Stephen" sort="Sarfo, Stephen" uniqKey="Sarfo S" first="Stephen" last="Sarfo">Stephen Sarfo</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Medicine, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Appiah, Lambert T" sort="Appiah, Lambert T" uniqKey="Appiah L" first="Lambert T." last="Appiah">Lambert T. Appiah</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Medicine, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Norman, Betty" sort="Norman, Betty" uniqKey="Norman B" first="Betty" last="Norman">Betty Norman</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Medicine, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Balakrishnan, Indran" sort="Balakrishnan, Indran" uniqKey="Balakrishnan I" first="Indran" last="Balakrishnan">Indran Balakrishnan</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Microbiology, The Royal Free Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Medicine, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chadwick, David" sort="Chadwick, David" uniqKey="Chadwick D" first="David" last="Chadwick">David Chadwick</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Infection & Travel Medicine, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0033262</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0033262 INIST</idno>
<idno type="RBID">Pascal:11-0033262</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000032</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana</title>
<author><name sortKey="Mamoojee, Yaasir" sort="Mamoojee, Yaasir" uniqKey="Mamoojee Y" first="Yaasir" last="Mamoojee">Yaasir Mamoojee</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Infection & Travel Medicine, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Shakoor, Shaid" sort="Shakoor, Shaid" uniqKey="Shakoor S" first="Shaid" last="Shakoor">Shaid Shakoor</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Infection & Travel Medicine, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gorton, Rebecca L" sort="Gorton, Rebecca L" uniqKey="Gorton R" first="Rebecca L." last="Gorton">Rebecca L. Gorton</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Microbiology, The Royal Free Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sarfo, Stephen" sort="Sarfo, Stephen" uniqKey="Sarfo S" first="Stephen" last="Sarfo">Stephen Sarfo</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Medicine, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Appiah, Lambert T" sort="Appiah, Lambert T" uniqKey="Appiah L" first="Lambert T." last="Appiah">Lambert T. Appiah</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Medicine, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Norman, Betty" sort="Norman, Betty" uniqKey="Norman B" first="Betty" last="Norman">Betty Norman</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Medicine, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Balakrishnan, Indran" sort="Balakrishnan, Indran" uniqKey="Balakrishnan I" first="Indran" last="Balakrishnan">Indran Balakrishnan</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Microbiology, The Royal Free Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Medicine, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chadwick, David" sort="Chadwick, David" uniqKey="Chadwick D" first="David" last="Chadwick">David Chadwick</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Infection & Travel Medicine, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">TM & IH. Tropical medicine & international health</title>
<title level="j" type="abbreviated">TM IH, Trop. med. int. health</title>
<idno type="ISSN">1360-2276</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">TM & IH. Tropical medicine & international health</title>
<title level="j" type="abbreviated">TM IH, Trop. med. int. health</title>
<idno type="ISSN">1360-2276</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term>
<term>Advanced stage</term>
<term>Antigen</term>
<term>Antiretroviral agent</term>
<term>Antiviral</term>
<term>Blood</term>
<term>Cryptococcosis</term>
<term>Epidemiology</term>
<term>Ghana</term>
<term>Human</term>
<term>Human immunodeficiency virus</term>
<term>Prevalence</term>
<term>Serology</term>
<term>Tropical medicine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>SIDA</term>
<term>Sérologie</term>
<term>Antiviral</term>
<term>Prévalence</term>
<term>Cryptococcose</term>
<term>Antigène</term>
<term>Homme</term>
<term>Virus immunodéficience humaine</term>
<term>Sang</term>
<term>Stade avancé</term>
<term>Antirétroviral</term>
<term>Ghana</term>
<term>Epidémiologie</term>
<term>Médecine tropicale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">OBJECTIVES To determine the prevalence of cryptococcal antigenaemia in a clinic population with advanced HIV infection, with a view to giving antifungal therapy to those testing positive. METHODS Serum samples from adults with CD4 count <100 cells/mm<sup>3</sup>
presenting to a large HIV clinic in Kumasi, Ghana, were tested retrospectively for cryptococcal antigenaemia using a latex agglutination assay, and clinical and demographic data extracted from case notes. RESULTS Of 92 samples tested, two were positive thus giving a prevalence of 2% (95% CI, 0-5.2%). CONCLUSIONS The prevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme appears to be low in Kumasi, suggesting that the value of routine testing of outpatients diagnosed with advanced HIV infection may be limited in this population.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1360-2276</s0>
</fA01>
<fA03 i2="1"><s0>TM IH, Trop. med. int. health</s0>
</fA03>
<fA05><s2>16</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MAMOOJEE (Yaasir)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SHAKOOR (Shaid)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>GORTON (Rebecca L.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>SARFO (Stephen)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>APPIAH (Lambert T.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>NORMAN (Betty)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>BALAKRISHNAN (Indran)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>PHILLIPS (Richard)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>CHADWICK (David)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Infection & Travel Medicine, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Microbiology, The Royal Free Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Medicine, Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA20><s1>53-56</s1>
</fA20>
<fA21><s1>2011</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>26295</s2>
<s5>354000194051910070</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>1/2 p.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>11-0033262</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>TM & IH. Tropical medicine & international health</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>OBJECTIVES To determine the prevalence of cryptococcal antigenaemia in a clinic population with advanced HIV infection, with a view to giving antifungal therapy to those testing positive. METHODS Serum samples from adults with CD4 count <100 cells/mm<sup>3</sup>
presenting to a large HIV clinic in Kumasi, Ghana, were tested retrospectively for cryptococcal antigenaemia using a latex agglutination assay, and clinical and demographic data extracted from case notes. RESULTS Of 92 samples tested, two were positive thus giving a prevalence of 2% (95% CI, 0-5.2%). CONCLUSIONS The prevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme appears to be low in Kumasi, suggesting that the value of routine testing of outpatients diagnosed with advanced HIV infection may be limited in this population.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B01</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05D02L</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B05C02D</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>SIDA</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>AIDS</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>SIDA</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Sérologie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Serology</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Serología</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Prévalence</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Prevalence</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Prevalencia</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Cryptococcose</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Cryptococcosis</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Criptococosis</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Antigène</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Antigen</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Antígeno</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Homme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Human</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Hombre</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Virus immunodéficience humaine</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Sang</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Blood</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Sangre</s0>
<s5>13</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Stade avancé</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Advanced stage</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Estadio avanzado</s0>
<s5>14</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Antirétroviral</s0>
<s5>15</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Antiretroviral agent</s0>
<s5>15</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Antiretroviral</s0>
<s5>15</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Ghana</s0>
<s2>NG</s2>
<s5>16</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Ghana</s0>
<s2>NG</s2>
<s5>16</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Ghana</s0>
<s2>NG</s2>
<s5>16</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Médecine tropicale</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Tropical medicine</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Medicina tropical</s0>
<s5>19</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Mycose</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Mycosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Micosis</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Afrique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Immunodéficit</s0>
<s5>37</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Immune deficiency</s0>
<s5>37</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Inmunodeficiencia</s0>
<s5>37</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>39</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>39</s5>
</fC07>
<fN21><s1>024</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 11-0033262 INIST</NO>
<ET>Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana</ET>
<AU>MAMOOJEE (Yaasir); SHAKOOR (Shaid); GORTON (Rebecca L.); SARFO (Stephen); APPIAH (Lambert T.); NORMAN (Betty); BALAKRISHNAN (Indran); PHILLIPS (Richard); CHADWICK (David)</AU>
<AF>Department of Infection & Travel Medicine, The James Cook University Hospital/Middlesbrough/Royaume-Uni (1 aut., 2 aut., 9 aut.); Department of Microbiology, The Royal Free Hospital/London/Royaume-Uni (3 aut., 7 aut.); Department of Medicine, Komfo Anokye Teaching Hospital/Kumasi/Ghana (4 aut., 5 aut., 6 aut., 8 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>TM & IH. Tropical medicine & international health; ISSN 1360-2276; Royaume-Uni; Da. 2011; Vol. 16; No. 1; Pp. 53-56; Bibl. 1/2 p.</SO>
<LA>Anglais</LA>
<EA>OBJECTIVES To determine the prevalence of cryptococcal antigenaemia in a clinic population with advanced HIV infection, with a view to giving antifungal therapy to those testing positive. METHODS Serum samples from adults with CD4 count <100 cells/mm<sup>3</sup>
presenting to a large HIV clinic in Kumasi, Ghana, were tested retrospectively for cryptococcal antigenaemia using a latex agglutination assay, and clinical and demographic data extracted from case notes. RESULTS Of 92 samples tested, two were positive thus giving a prevalence of 2% (95% CI, 0-5.2%). CONCLUSIONS The prevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme appears to be low in Kumasi, suggesting that the value of routine testing of outpatients diagnosed with advanced HIV infection may be limited in this population.</EA>
<CC>002B01; 002B05D02L; 002B05C02D</CC>
<FD>SIDA; Sérologie; Antiviral; Prévalence; Cryptococcose; Antigène; Homme; Virus immunodéficience humaine; Sang; Stade avancé; Antirétroviral; Ghana; Epidémiologie; Médecine tropicale</FD>
<FG>Virose; Infection; Mycose; Lentivirus; Retroviridae; Virus; Afrique; Immunodéficit; Immunopathologie</FG>
<ED>AIDS; Serology; Antiviral; Prevalence; Cryptococcosis; Antigen; Human; Human immunodeficiency virus; Blood; Advanced stage; Antiretroviral agent; Ghana; Epidemiology; Tropical medicine</ED>
<EG>Viral disease; Infection; Mycosis; Lentivirus; Retroviridae; Virus; Africa; Immune deficiency; Immunopathology</EG>
<SD>SIDA; Serología; Antiviral; Prevalencia; Criptococosis; Antígeno; Hombre; Human immunodeficiency virus; Sangre; Estadio avanzado; Antiretroviral; Ghana; Epidemiología; Medicina tropical</SD>
<LO>INIST-26295.354000194051910070</LO>
<ID>11-0033262</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000032 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000032 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaGhanaV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:11-0033262 |texte= Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana }}
This area was generated with Dilib version V0.6.31. |